Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Axogen, Inc. Director's Dealing 2025

Sep 16, 2025

32414_dirs_2025-09-16_f2a1dc0c-af60-4f88-8f5b-df59a40cad46.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2025-09-13

Reporting Person: DeVinney Erick Wayne (Chief Innovation Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-09-13 Common Stock A 2500 Acquired 221786 Direct
2025-09-16 Common Stock S 1137 $16.29 Disposed 220649 Direct

Footnotes

F1: This reflects the number of shares issued upon the attainment of certain performance criteria.

F2: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance stock units ("PSUs") on September 13, 2025. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.